Cumberland Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.3 |
Market Cap |
$99.13 M |
Shares Outstanding |
15.54 M |
Public Float |
8.96 M |
Address |
2525 West End Avenue Nashville Tennessee 37203 United States |
Employees | - |
Website | http://www.cumberlandpharma.com |
Updated | 07/08/2019 |
Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of brands for the hospital acute care, gastroenterology, and oncology. Its product brands include acetadote, caldolor, kristalose, hepatoren, omeclamox, vaprisol, boxaban, vasculan, ethyol, portaban, and totect. The company was founded by A. |